Literature DB >> 13319578

The properdin system and immunity. V. The bactericidal activity of the properdin system.

A C WARDLAW, L PILLEMER.   

Abstract

Methods for the preparation and standardization of reagents suitable for studies on the bactericidal action of the properdin system are described. The preparation and properties of serum free of properdin (RP(b)) are presented in detail because of the necessity for a suitable RP(b) in these studies. The properdin system is responsible for the bactericidal action of normal human serum against a variety of microorganisms. The present work shows that the removal of properdin from serum also removes bactericidal activity. Addition of properdin to properdin-deficient serum restores bactericidal activity. A quantitative relationship exists between the final properdin concentration and bactericidal activity against sensitive organisms. The possibilities of a bactericidal assay for properdin are discussed. It is demonstrated that, in addition to properdin, the four components of complement (present in RP(b)) are necessary for the destruction of properdinsensitive bacteria. If any component is missing, bactericidal activity is lost; when the component is replaced, bactericidal activity is restored. Magnesium is also necessary for the bactericidal activity of the properdin system. Maximal bactericidal activity is obtained with magnesium concentrations similar to that of normal human serum (10(-3) to 10(-4)M). The bactericidal activity of the properdin system occurs only at temperatures above 15 degrees . Resistant strains have been encountered in species of bacteria sensitive to the properdin system. Resistance or sensitivity is a characteristic of the individual strain and not of the species. The widespread occurrence of the properdin system in normal mammalian serum and the variety of bacteria destroyed by it suggest that the properdin system is a factor in natural resistance.

Entities:  

Keywords:  COMPLEMENT; IMMUNITY; MAGNESIUM/effects; SERUM GLOBULIN; TEMPERATURE/effects

Mesh:

Substances:

Year:  1956        PMID: 13319578      PMCID: PMC2136629          DOI: 10.1084/jem.103.5.553

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  8 in total

1.  Serum properdin levels in hemorrhagic shock.

Authors:  E FRANK; J FINE; L PILLEMER
Journal:  Proc Soc Exp Biol Med       Date:  1955-06

2.  Stimulation of natural immunity to Escherichia coli infection: observations on mice.

Authors:  D ROWLEY
Journal:  Lancet       Date:  1955-01-29       Impact factor: 79.321

3.  Properdin system and immunity. II. Interaction of the properdin system with polysaccharides.

Authors:  L PILLEMER; M D SCHOENBERG; L BLUM; L WURZ
Journal:  Science       Date:  1955-09-23       Impact factor: 47.728

4.  Studies on the mechanism of inactivation of human complement by plasmin and by antigen-antibody aggregates. I. The requirement for a factor resembling C'1 and the role of Ca++.

Authors:  I H LEPOW; L WURZ; O D RATNOFF; L PILLEMER
Journal:  J Immunol       Date:  1954-09       Impact factor: 5.422

5.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

6.  A labile component of normal serum which combines with various viruses; neutralization of infectivity and inhibition of hemagglutination by the component.

Authors:  H S GINSBERG; F L HORSFALL
Journal:  J Exp Med       Date:  1949-11       Impact factor: 14.307

7.  The properdin system and immunity. III. The zymosan assay of properdin.

Authors:  L PILLEMER; L BLUM; I H LEPOW; L WURZ; E W TODD
Journal:  J Exp Med       Date:  1956-01-01       Impact factor: 14.307

8.  The inactivation of complement and its components by plasmin.

Authors:  L PILLEMER; O D RATNOFF; L BLUM; I H LEPOW
Journal:  J Exp Med       Date:  1953-04       Impact factor: 14.307

  8 in total
  67 in total

1.  [SERUM PROPERDIN IN THE COURSE OF VIRUS DISEASES. DETERMINED ON AN EXAMPLE OF HEPATITIS].

Authors:  F SCHEIFFARTH; K D TYMPNER; W FRENGER
Journal:  Klin Wochenschr       Date:  1964-04-15

2.  Development of bactericidal properties against gram-negative organisms in the serum of young animals.

Authors:  J STERZL; J KOSTKA; A LANC
Journal:  Folia Microbiol (Praha)       Date:  1962-05       Impact factor: 2.099

3.  [Methodological and clinical studies on the properdin system. III. Studies on the behavior of 4 complement components after major gynecological operations].

Authors:  G SCHUMACHER; H D SCHLUMBERGER
Journal:  Arch Gynakol       Date:  1961

4.  Infection of burns.

Authors:  E J LOWBURY
Journal:  Br Med J       Date:  1960-04-02

5.  Serum and tissue inhibitors of virus.

Authors:  H S GINSBERG
Journal:  Bacteriol Rev       Date:  1960-03

6.  The growth and death of wound bacteria in serum, exudate and slough.

Authors:  L COLEBROOK; E J LOWBURY; L HURST
Journal:  J Hyg (Lond)       Date:  1960-12

7.  [Methodical and clinical research on the properdin system. II. Research on the behavior of the serum properdin and the C'3 components after gynecological operations].

Authors:  G SCHUMACHER; E EL HABASH; H D SCHLUMBERGER
Journal:  Arch Gynakol       Date:  1961

8.  [Methodical and clinical research on the properdin system. I. Methodical research on the simplified properdin test according to Isliker].

Authors:  G SCHUMACHER; F KNIERIM; H D SCHLUMBERGER
Journal:  Arch Gynakol       Date:  1961

9.  [The properdin system and antibody formation. I. The serum properdin level in rabbits during immunization with Mycobacterium tuberculosis].

Authors:  H WAHLIG
Journal:  Arch Mikrobiol       Date:  1959

10.  [The properdin problem].

Authors:  H E SCHULTZE; G SCHWICK
Journal:  Blut       Date:  1958-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.